UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UBS Group
UBS
|
+$1.48B |
| 2 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$690M |
| 3 |
VanEck Junior Gold Miners ETF
GDXJ
|
+$588M |
| 4 |
Truist Financial
TFC
|
+$532M |
| 5 |
VanEck Gold Miners ETF
GDX
|
+$278M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.3B |
| 2 |
Alibaba
BABA
|
+$771M |
| 3 |
AABA
Altaba Inc
AABA
|
+$759M |
| 4 |
STI
SunTrust Banks, Inc.
STI
|
+$503M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$467M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.82% |
| 2 | Financials | 7.38% |
| 3 | Healthcare | 6.65% |
| 4 | Consumer Discretionary | 5.46% |
| 5 | Industrials | 5.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
826
PUT
United Airlines
UAL
$39.4B
| $45.9M | 0.02% |
521,100
-11,200
| -2% | -$1.01M |
|
827
Expedia Group
EXPE
$35.4B
| $45.8M | 0.02% |
423,469
+196,553
| +87% | +$23.1M |
|
|
CIM
828
Chimera Investment
CIM
$1.04B
| $45.8M | 0.02% |
742,300
-234,519
| -24% | -$14.3M |
|
|
SGI
829
Somnigroup International
SGI
$13.7B
| $45.7M | 0.02% |
2,100,452
+968,192
| +86% | +$20.2M |
|
|
AXE
830
DELISTED
Anixter International Inc
AXE
| $45.6M | 0.02% |
495,252
+471,223
| +1,961% | +$38.2M |
|
831
PUT
Merck
MRK
$322B
| $45.6M | 0.02% |
525,467
+28,401
| +6% | +$2.33M |
|
832
iShares Silver Trust
SLV
$28B
| $45.6M | 0.02% |
2,731,803
+189,413
| +7% | +$3.07M |
|
833
ALPS Sector Dividend Dogs ETF
SDOG
$1.4B
| $45.3M | 0.02% |
967,249
-20,355
| -2% | -$918K |
|
834
Vanguard Industrials ETF
VIS
$8.1B
| $45.2M | 0.02% |
293,972
-9,040
| -3% | -$1.36M |
|
835
Regeneron Pharmaceuticals
REGN
$78.5B
| $45.2M | 0.02% |
120,442
-20,670
| -15% | -$6.95M |
|
836
Advance Auto Parts
AAP
$3.35B
| $45.2M | 0.02% |
282,041
-169,513
| -38% | -$27.2M |
|
|
BOLD
837
DELISTED
Audentes Therapeutics, Inc
BOLD
| $45M | 0.02% |
752,003
+650,385
| +640% | +$24.4M |
|
838
Carvana
CVNA
$68.6B
| $44.9M | 0.02% |
2,440,380
-1,209,270
| -33% | -$20.2M |
|
839
DTE Energy
DTE
$29.5B
| $44.9M | 0.02% |
406,398
+246,065
| +153% | +$26.5M |
|
840
Leidos
LDOS
$14.5B
| $44.5M | 0.02% |
454,655
+11,739
| +3% | +$1.03M |
|
841
Deutsche Bank
DB
$69B
| $44.5M | 0.02% |
5,717,578
-3,459,607
| -38% | -$26M |
|
842
iShares Morningstar Mid-Cap ETF
IMCB
$1.65B
| $44.4M | 0.02% |
847,056
+7,240
| +0.9% | +$367K |
|
843
VanEck Intermediate Muni ETF
ITM
$2.14B
| $44.4M | 0.02% |
883,223
+93,805
| +12% | +$4.71M |
|
844
iShares US Healthcare ETF
IYH
$3.37B
| $44.4M | 0.02% |
1,028,185
-19,595
| -2% | -$791K |
|
845
Apollo Global Management
APO
$72.4B
| $44.3M | 0.02% |
927,919
-539,752
| -37% | -$23M |
|
|
JPUS
846
JPMorgan Diversified Return US Equity ETF
JPUS
$458M
| $44M | 0.02% |
552,194
-67,495
| -11% | -$5.21M |
|
847
PUT
General Motors
GM
$80.4B
| $44M | 0.02% |
1,201,500
-234,700
| -16% | -$8.53M |
|
848
PUT
Procter & Gamble
PG
$336B
| $43.9M | 0.02% |
351,700
-14,700
| -4% | -$1.8M |
|
849
SS&C Technologies
SSNC
$18.1B
| $43.9M | 0.02% |
715,377
+42,333
| +6% | +$2.37M |
|
850
CALL
Global Payments
GPN
$23B
| $43.9M | 0.02% |
+240,300
| New | +$41.2M |
|
Similar funds
UBS Group's Q4 2019 Portfolio in Review
As of Q4 2019, UBS Group held 8,864 positions worth $287B, up 11% from $260B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
UBS Group's Q4 2019 filing shows 808 new, 4,307 increased, 2,684 reduced and 688 closed positions. Its largest new stake was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.3B.
By sector, the portfolio is most concentrated in Technology at 9.8% of assets, up from 9.5% a quarter earlier, followed by Financials and Healthcare.
- UBS Group's largest Q4 2019 buy was Bristol-Myers Squibb Company Contingent Value Rights: 5,302,748 shares worth $16M.
- UBS Group added most to UBS Group in Q4 2019, an estimated $1.48B increase.
- UBS Group's biggest Q4 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.3B.
- UBS Group fully exited Altaba Inc in Q4 2019, selling an estimated $759M.
- UBS Group's ten largest holdings make up 13% of its $287B portfolio in Q4 2019.
- UBS Group opened 808 new positions and closed 688 in Q4 2019.
- UBS Group's portfolio value rose 11% quarter-over-quarter to $287B.
Based on UBS Group's 13F filing for Q4 2019, filed 14 Feb 2020.